BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36208048)

  • 41. [Clinicopathological features of low-grade oncocytic renal tumor (CD117-negative, cytokeratin 7-positive): report of seven cases].
    Xie B; Cheng LC; Yin GL; Liu BA; Hu ZL; Tong K
    Zhonghua Bing Li Xue Za Zhi; 2022 Aug; 51(8):719-725. PubMed ID: 35922161
    [No Abstract]   [Full Text] [Related]  

  • 42. [Eosinophilic, solid, and cystic renal cell carcinoma (ESC-RCC)].
    Hartmann A; Agaimy A
    Pathologe; 2021 Nov; 42(6):565-570. PubMed ID: 34550432
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumour (PEComa): genetic evidence for the relationship of PEComa with angiomyolipoma.
    Pan CC; Chung MY; Ng KF; Liu CY; Wang JS; Chai CY; Huang SH; Chen PC; Ho DM
    J Pathol; 2008 Feb; 214(3):387-93. PubMed ID: 18085521
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hybrid oncocytic/chromophobe renal cell tumours do not display genomic features of chromophobe renal cell carcinomas.
    Poté N; Vieillefond A; Couturier J; Arrufat S; Metzger I; Delongchamps NB; Camparo P; Mège-Lechevallier F; Molinié V; Sibony M
    Virchows Arch; 2013 Jun; 462(6):633-8. PubMed ID: 23708994
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.
    Tan MH; Wong CF; Tan HL; Yang XJ; Ditlev J; Matsuda D; Khoo SK; Sugimura J; Fujioka T; Furge KA; Kort E; Giraud S; Ferlicot S; Vielh P; Amsellem-Ouazana D; Debré B; Flam T; Thiounn N; Zerbib M; Benoît G; Droupy S; Molinié V; Vieillefond A; Tan PH; Richard S; Teh BT
    BMC Cancer; 2010 May; 10():196. PubMed ID: 20462447
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Oncocytic tumours of the kidney-new differential diagnoses].
    Polifka I; Ohashi R; Moch H
    Pathologe; 2021 Nov; 42(6):551-559. PubMed ID: 34468818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. "Oncocytoid Renal Cell Carcinomas After Neuroblastoma" Represent TSC -mutated Eosinophilic Solid and Cystic Renal Cell Carcinomas : Association With Prior Childhood Malignancy and Multifocality With Therapeutic Implications.
    Argani P; Medeiros LJ; Matoso A; Baraban E; Lotan T; Pawel BR; McKenney JK; Mehra R; Falzarano SM; Pallavajjalla A; Lin MT; Patel S; Rawwas J; Bendel AE; Gagan J; Palsgrove DN
    Am J Surg Pathol; 2023 Dec; 47(12):1335-1348. PubMed ID: 37522346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Concordance of MTOR Pathway Mutations and the Diagnosis of Renal Low-Grade Oncocytic Tumor (LOT).
    Siegmund SE; Al-Obaidy KI; Tsai HK; Idrees MT; Akgul M; Acosta AM; Hirsch MS
    Int J Surg Pathol; 2024 Apr; 32(2):316-330. PubMed ID: 37357748
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal oncocytosis: a clinicopathological and cytogenetic study of 42 tumours occurring in 11 patients.
    Giunchi F; Fiorentino M; Vagnoni V; Capizzi E; Bertolo R; Porpiglia F; Vatrano S; Tamberi S; Schiavina R; Papotti M; Bollito E
    Pathology; 2016 Jan; 48(1):41-6. PubMed ID: 27020208
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New Mechanisms of mTOR Pathway Activation in KIT-mutant Malignant GISTs.
    Lasota J; Kowalik A; Felisiak-Golabek A; Zięba S; Wang ZF; Miettinen M
    Appl Immunohistochem Mol Morphol; 2019 Jan; 27(1):54-58. PubMed ID: 28777148
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gene expression profiling separates chromophobe renal cell carcinoma from oncocytoma and identifies vesicular transport and cell junction proteins as differentially expressed genes.
    Rohan S; Tu JJ; Kao J; Mukherjee P; Campagne F; Zhou XK; Hyjek E; Alonso MA; Chen YT
    Clin Cancer Res; 2006 Dec; 12(23):6937-45. PubMed ID: 17145811
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Ho DWH; Chan LK; Chiu YT; Xu IMJ; Poon RTP; Cheung TT; Tang CN; Tang VWL; Lo ILO; Lam PWY; Yau DTW; Li MX; Wong CM; Ng IOL
    Gut; 2017 Aug; 66(8):1496-1506. PubMed ID: 27974549
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oncocytoma-like renal tumor with transformation toward high-grade oncocytic carcinoma: a unique case with morphologic, immunohistochemical, and genomic characterization.
    Sirintrapun SJ; Geisinger KR; Cimic A; Snow A; Hagenkord J; Monzon F; Legendre BL; Ghazalpour A; Bender RP; Gatalica Z
    Medicine (Baltimore); 2014 Oct; 93(15):e81. PubMed ID: 25275525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy.
    Caliò A; Marletta S; Settanni G; Rizzo M; Gobbo S; Pedron S; Stefanizzi L; Munari E; Brunelli M; Marcolini L; Pesci A; Fratoni S; Pierconti F; Raspollini MR; Marchetti A; Doglioni C; Amin MB; Porta C; Martignoni G
    Virchows Arch; 2023 Dec; 483(6):821-833. PubMed ID: 37938323
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Somatic Bi-allelic Loss of TSC Genes in Eosinophilic Solid and Cystic Renal Cell Carcinoma.
    Mehra R; Vats P; Cao X; Su F; Lee ND; Lonigro R; Premkumar K; Trpkov K; McKenney JK; Dhanasekaran SM; Chinnaiyan AM
    Eur Urol; 2018 Oct; 74(4):483-486. PubMed ID: 29941307
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinicopathological features of hybrid oncocytic/chromophobe renal cell tumor].
    Wang Y; Chong DC; Xin FJ; He B; Liu XL; Li YJ; Zhang W; Jiang YX
    Zhonghua Bing Li Xue Za Zhi; 2021 Feb; 50(2):97-102. PubMed ID: 33535302
    [No Abstract]   [Full Text] [Related]  

  • 57. Sclerosing TSC1 mutated renal cell carcinoma: An unusual pattern mimicking MITF family translocation renal cell carcinoma.
    Williamson SR; Cardili L; Whiteley LJ; Sanchez J; Kis O
    Genes Chromosomes Cancer; 2020 Oct; 59(10):591-594. PubMed ID: 32418252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
    Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
    Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New insights in the new WHO classification of adult renal tumors.
    Hes O; Michalová K; Pivovarčíková K
    Cesk Patol; 2022; 67(4):187-191. PubMed ID: 36513503
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists.
    Williamson SR; Gadde R; Trpkov K; Hirsch MS; Srigley JR; Reuter VE; Cheng L; Kunju LP; Barod R; Rogers CG; Delahunt B; Hes O; Eble JN; Zhou M; McKenney JK; Martignoni G; Fleming S; Grignon DJ; Moch H; Gupta NS
    Hum Pathol; 2017 May; 63():149-156. PubMed ID: 28315424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.